Expanded Hemodialysis Therapy Market Growth, Size, Trends, Revenue, Share and Future Outlook

Expanded Hemodialysis Therapy Market Size- Product, By Modality, Application By End user- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Expanded Hemodialysis Therapy Market Size- Product, By Modality, Application By End user- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Nov 2023 Report ID: HLCA2365 Pages: 1 - 235 Formats*:     
Category : Healthcare
Expanded Hemodialysis Therapy Market Introduction and Overview 

According to SPER Market Research, the Global Expanded Hemodialysis Therapy Market is estimated to reach USD XX billion by 2033 with a CAGR of 5.0%.

The report includes an in-depth analysis of the Global Expanded Hemodialysis Therapy market, including market size and trends, product mix, distribution channels, and supplier analysis. A life-sustaining treatment for patients with end-stage kidney disease is hemodialysis. It assists in the blood's removal of waste materials, extra fluid, and electrolytes, all of which help control and lessen kidney failure symptoms. Hemodialysis is not a cure for kidney disease, although it can greatly enhance many patients' quality of life. For a few, it acts as a stopgap measure before kidney transplantation, the permanent cure for kidney failure.
Expanded Hemodialysis Therapy Market
Market Opportunities and Challenges

Opportunities: The growing number of people worldwide who suffer from chronic renal illnesses. Due to the fact that kidney failure halts the process of cleansing blood and waste outflow, innovative medical devices must be used externally to filter the blood. Therefore, it is projected that throughout the forecast period, the growing prevalence of chronic renal disorders worldwide would present profitable potential prospects for market expansion. Furthermore, Diabetes and hypertension have increased significantly in recent years as a result of poor diet, sedentary lifestyle, limited physical exercise, increasing alcohol intake, and other factors. People who have such disorders are thought to be more likely to acquire a kidney ailment. Thus, renal failure due to lifestyle illnesses is expected to boost adoption of expanded hemodialysis therapy and, as a result, market size.

Challenges: The risks and complications that come with dialysis Patients receiving expanded hemodialysis treatments can have severe side effects while receiving treatment. Anemia, or the body's lack of red blood cells, is one of the most frequent side effects. Additionally, patients undergoing extended hemodialysis may have body-wide pain, warmth, redness, and swelling. Combined, these challenges will make it difficult for the industry to grow throughout the projected timeframe. The dialysis market is extremely competitive and diverse due to its large number of competitors. In the hemodialyser and peritoneal dialysis market, Tier I companies, mid-tier companies, and start-up companies all compete. Businesses are trying to get visibility in the market in this fiercely competitive field.

Expanded Hemodialysis Therapy Market

Market Competitive Landscape
The market for Expanded Hemodialysis Therapy is highly consolidated. Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc. Some of the market key players in global Expanded Hemodialysis Therapy market.

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy Product, By Modality, Application By End User
 Regions coveredNorth America, Asia-Pacific, Latin America, Middle East & Africa and Europe
 Companies CoveredAsahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc.
COVID-19 Impact on Global Expanded Hemodialysis Therapy Market
The COVID-19 pandemic impacted nearly all industries and caused severe financial difficulty for healthcare services by rising healthcare costs. The adoption of social distancing norms and the change of standard operating procedures impeded the day-to-day functioning of numerous healthcare services, including dialysis processes. Many hospitals halted or rescheduled routine care and only offered emergency care. Despite the coronavirus epidemic, emergency dialysis procedures were performed in medical facilities. As the number of COVID-19 cases dropped in numerous countries, healthcare facilities resumed delivering healthcare services, eventually returning to pre-pandemic levels and positively improving the market landscape.

Key Target Audience
  • Nephrologists and Healthcare Providers
  • Dialysis Centers and Hospitals
  • Patients with Kidney Disease
  • Caregivers and Family Members
  • Medical Device Manufacturers 
  • Pharmaceutical Companies
  • Healthcare Insurers and Payers
  • Regulatory Agencies
  • Researchers and Academics
Our in-depth analysis of the Expanded Hemodialysis Therapy Market includes the following segments:
By Product:
  • Machine
  • Dialyzers
  • Concentrates
  • Dialysates
  • Catheters
  • By Modality:
  • Short Daily
  • Conventional Long term
  • Nocturnal
  • By Application:
  • Priced Equipment
  • Service
  • Consumable
  • Drug
  • By End Use:
  • Hospital
  • Independent Dialysis
  • Home Dialysis
  • By Region:
  • Asia-Pacific
  • Europe
  • Middle East & Africa
  • North America
  • Latin America
  • Key Topics Covered in the Report
    • Global Expanded Hemodialysis Therapy Market Size (FY’2023-FY’2033)
    • Overview of Global Expanded Hemodialysis Therapy Market
    • Segmentation of Global Expanded Hemodialysis Therapy Market By Product (Machine, Dialyzers, Concentrates, Dialysates, Catheters)
    • Segmentation of Global Expanded Hemodialysis Therapy Market By Modality (Short Daily, Conventional Long Term, Nocturnal)
    • Segmentation of Global Expanded Hemodialysis Therapy Market By Application (Priced Equipment, Service, Consumable, Drug)
    • Segmentation of Global Expanded Hemodialysis Therapy Market By End User (Hospital, Independent Dialysis, Home Dialysis)
    • Statistical Snap of Global Expanded Hemodialysis Therapy Market
    • Expansion Analysis of Global Expanded Hemodialysis Therapy Market
    • Problems and Obstacles in Global Expanded Hemodialysis Therapy Market
    • Competitive Landscape in the Global Expanded Hemodialysis Therapy Market
    • Impact of COVID-19 and Demonetization on Global Expanded Hemodialysis Therapy Market
    • Details on Current Investment in Global Expanded Hemodialysis Therapy  Market
    • Competitive Analysis of Global Expanded Hemodialysis Therapy  Market
    • Prominent Players in the Global Expanded Hemodialysis Therapy  Market
    • SWOT Analysis of Global Expanded Hemodialysis Therapy  Market
    • Global Expanded Hemodialysis Therapy  Market Future Outlook and Projections (FY’2023-FY’2033)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Global Expanded Hemodialysis Therapy Market

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Global Expanded Hemodialysis Therapy Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Expanded Hemodialysis Therapy Market 

    7. Global Expanded Hemodialysis Therapy Market, By Product (USD Million)
    7.1. Global Expanded Hemodialysis Therapy Market Value Share and Forecast, By Product, 2023-2033
    7.2. Machine
    7.3. Dialyzers
    7.4. Concentrates
    7.5. Dialysates
    7.6. Catheters

    8. Global Expanded Hemodialysis Therapy Market , By Modality (USD Million)
    8.1. Global Expanded Hemodialysis Therapy Market  Value Share and Forecast, By Modality, 2023-2033
    8.2. Short Daily
    8.3. Conventional Long term
    8.4. Nocturnal

    9. Global Expanded Hemodialysis Therapy Market , By Application (USD Million)
    9.1. Global Expanded Hemodialysis Therapy Market  Value Share and Forecast, By Application, 2023-2033
    9.2. Priced Equipment
    9.3. Service
    9.4. Consumable
    9.5. Drug

    10. Global Expanded Hemodialysis Therapy Market , By End Use (USD Million)
    10.1. Global Expanded Hemodialysis Therapy Market  Value Share and Forecast, By End Use, 2023-2033
    10.2. Hospital
    10.3. Independent Dialysis
    10.4. Home Dialysis

    11. Global Expanded Hemodialysis Therapy Market Forecast, 2019-2033 (USD Million)
    11.1. Global Expanded Hemodialysis Therapy Market Size and Market Share

    12. Global Expanded Hemodialysis Therapy Market, By Product, 2019-2033 (USD Million)
    12.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Product (2019-2026)
    12.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Product (2027-2033)

    13. Global Expanded Hemodialysis Therapy Market, By Modality, 2019-2033 (USD Million)
    13.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Modality (2019-2026)
    13.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Modality (2027-2033)

    14. Global Expanded Hemodialysis Therapy Market, By Application, 2019-2033 (USD Million)
    14.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Application (2019-2026)
    14.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Application (2027-2033)

    15. Global Expanded Hemodialysis Therapy Market, By End User, 2019-2033 (USD Million)
    15.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By End User (2019-2026)
    15.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By End User (2027-2033)

    16. Global Expanded Hemodialysis Therapy Market, By Region, 2019-2033 (USD Million)
    16.1. Global Expanded Hemodialysis Therapy Market Size and Market Share By Region (2019-2026)
    16.2. Global Expanded Hemodialysis Therapy Market Size and Market Share By Region (2027-2033)
    16.3. Asia-Pacific
    16.3.1. Australia
    16.3.2. China
    16.3.3. India
    16.3.4. Japan
    16.3.5. South Korea
    16.3.6. Rest of Asia-Pacific
    16.4. Europe
    16.4.1. France
    16.4.2. Germany
    16.4.3. Italy
    16.4.4. Spain
    16.4.5. United Kingdom
    16.4.6. Rest of Europe
    16.5. Middle East and Africa
    16.5.1. Kingdom of Saudi Arabia 
    16.5.2. United Arab Emirates
    16.5.3. Rest of Middle East & Africa
    16.6. North America
    16.6.1. Canada
    16.6.2. Mexico
    16.6.3. United States
    16.7. Latin America
    16.7.1. Argentina
    16.7.2. Brazil
    16.7.3. Rest of Latin America

    17. Company Profile
    17.1. Asahi Kasei Corporation
    17.1.1. Company details
    17.1.2. Financial outlook
    17.1.3. Product summary 
    17.1.4. Recent developments
    17.2. B. Braun Melsungen AG
    17.2.1. Company details
    17.2.2. Financial outlook
    17.2.3. Product summary 
    17.2.4. Recent developments
    17.3. Baxter International Inc.
    17.3.1. Company details
    17.3.2. Financial outlook
    17.3.3. Product summary 
    17.3.4. Recent developments
    17.4. Cantel Medical Corp.
    17.4.1. Company details
    17.4.2. Financial outlook
    17.4.3. Product summary 
    17.4.4. Recent developments
    17.5. Fresenius Medical Care AG & Co. KGaA
    17.5.1. Company details
    17.5.2. Financial outlook
    17.5.3. Product summary 
    17.5.4. Recent developments
    17.6. Nikkiso Co, Ltd.
    17.6.1. Company details
    17.6.2. Financial outlook
    17.6.3. Product summary 
    17.6.4. Recent developments
    17.7. Nipro Corporation
    17.7.1. Company details
    17.7.2. Financial outlook
    17.7.3. Product summary 
    17.7.4. Recent developments
    17.8. NxStage Medical Corp. 
    17.8.1. Company details
    17.8.2. Financial outlook
    17.8.3. Product summary 
    17.8.4. Recent developments
    17.9. Satellite Healthcare Inc.
    17.9.1. Company details
    17.9.2. Financial outlook
    17.9.3. Product summary 
    17.9.4. Recent developments
    17.10. MEDIVATORS Inc.
    17.10.1. Company details
    17.10.2. Financial outlook
    17.10.3. Product summary 
    17.10.4. Recent developments
    17.11. Others 

    18. List of Abbreviations

    19. Reference Links

    20. Conclusion

    21. Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Expanded Hemodialysis Therapy Market is projected to reach USD XX billion by 2033, growing at a CAGR of 5.0% during the forecast period.
    Expanded Hemodialysis Therapy Market grew in market size from 2022. The Market is expected to reach USD XX billion by 2033, at a CAGR of 5.0% during the forecast period.
    Expanded Hemodialysis Therapy Market CAGR of 5.0% during the forecast period.
    Expanded Hemodialysis Therapy Market size is USD XX billion from 2023 to 2033.
    Expanded Hemodialysis Therapy Market Segment is covered By Product, By Modality, Application By End User.
    The North America is anticipated to have the highest market share in the Expanded Hemodialysis Therapy Market.
    The key players in the market include Companies Covered Covered Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co, Ltd., Nipro Corporation, NxStage Medical Corp., Satellite Healthcare Inc., MEDIVATORS Inc.
    A life-sustaining treatment for patients with end-stage kidney disease is hemodialysis. It assists in the blood's removal of waste materials, extra fluid, and electrolytes, all of which help control and lessen kidney failure symptoms.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here
    PLACE AN ORDER
    • 15% off
       
      $ 4250
    • 20% off
               
      $ 5650
    • 25% off
           
      $ 7450
    Pre-Purchase Inquiry
    SEND AN INQUIRY
    NEED CUSTOMIZATION?
    Request Customization
    CALL OR EMAIL US
    US:
    India:
    Email:
    100% Secure Payment

    SPER American Express
    SPER VISA
    SPER Master Card
    SPER Mestro
    SPER Paypal
    SPER CCAvenues

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-McKinsey
    SPER-Bain
    SPER-Max-Healthcare
    SPER-DHL
    SPER-SIEMENS
    SPER-IQVIA
    SPER-Pfizer
    SPER-LOREAL
    SPER-Kankar IMRB
    SPER-ITA
    SPER-PWC
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-IPSOS
    SPER-Heineken

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650